Defining rare conditions in the era of personalized medicine

Daniel J. O’Connor, Michela Gabaldo, Annemieke Aartsma-Rus, Anneliene Hechtelt Jonker

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The total number of rare conditions is debated, partly because of the variety of definitions of what constitutes rare. A broader consensus view of what rare means, based on improved understanding of individual group and patient clinicopathological characteristics, will help maximize the impact of technological advances in therapeutic development programmes.

Original languageEnglish
Pages (from-to)857-858
Number of pages2
JournalNature Reviews Drug Discovery
Volume22
Issue number11
DOIs
Publication statusPublished - Nov 2023

Keywords

  • NLA

Fingerprint

Dive into the research topics of 'Defining rare conditions in the era of personalized medicine'. Together they form a unique fingerprint.

Cite this